Detalles de la búsqueda
1.
Repotrectinib in ROS1 Fusion-Positive Non-Small-Cell Lung Cancer.
N Engl J Med
; 390(2): 118-131, 2024 Jan 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-38197815
2.
A phase Ib/II study of cadonilimab (PD-1/CTLA-4 bispecific antibody) plus anlotinib as first-line treatment in patients with advanced non-small cell lung cancer.
Br J Cancer
; 130(3): 450-456, 2024 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-38110665
3.
Loss-tolerant and quantum-enhanced interferometer by reversed squeezing processes.
Opt Lett
; 48(15): 3909-3912, 2023 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37527080
4.
Sugemalimab versus placebo, in combination with platinum-based chemotherapy, as first-line treatment of metastatic non-small-cell lung cancer (GEMSTONE-302): interim and final analyses of a double-blind, randomised, phase 3 clinical trial.
Lancet Oncol
; 23(2): 220-233, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-35038432
5.
Adebrelimab or placebo plus carboplatin and etoposide as first-line treatment for extensive-stage small-cell lung cancer (CAPSTONE-1): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet Oncol
; 23(6): 739-747, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35576956
6.
On-treatment blood TMB as predictors for camrelizumab plus chemotherapy in advanced lung squamous cell carcinoma: biomarker analysis of a phase III trial.
Mol Cancer
; 21(1): 4, 2022 01 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34980131
7.
Rapid titration with oral sustained-release morphine plus subcutaneous morphine in a multi-center, randomized control study of cancer patients with moderate to severe cancer pain.
Jpn J Clin Oncol
; 52(11): 1303-1310, 2022 Nov 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-35946332
8.
Circ_0047921 acts as the sponge of miR-1287-5p to stimulate lung cancer progression by regulating proliferation, migration, invasion, and glycolysis of lung cancer cells.
World J Surg Oncol
; 20(1): 108, 2022 Apr 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-35365169
9.
BRAF V600E Mediates Crizotinib Resistance and Responds to Dabrafenib and Trametinib in a ROS1-Rearranged Non-Small Cell Lung Cancer: A Case Report.
Oncologist
; 26(12): e2115-e2119, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34516041
10.
All-trans retinoic acid reduces cancer stem cell-like cell-mediated resistance to gefitinib in NSCLC adenocarcinoma cells.
BMC Cancer
; 20(1): 315, 2020 Apr 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-32293355
11.
Realizing a high-efficiency 426nm laser with PPKTP by reducing mode-mismatch caused by the thermal effect.
Opt Express
; 27(20): 28534-28543, 2019 Sep 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-31684603
12.
Clinical analysis of 1629 newly diagnosed malignant lymphomas in current residents of Sichuan province, China.
Hematol Oncol
; 34(4): 193-199, 2016 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-25824105
13.
Physicians' Practice, Attitudes Toward, and Knowledge of Cancer Pain Management in China.
Pain Med
; 16(11): 2195-203, 2015 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-26118400
14.
Survey on Chinese breast cancer patients' husbands toward breast conserving surgery.
J BUON
; 19(4): 887-94, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-25536591
15.
Myeloprotection with trilaciclib in Chinese patients with extensive-stage small cell lung cancer receiving chemotherapy: Results from a randomized, double-blind, placebo-controlled phase III study (TRACES).
Lung Cancer
; 188: 107455, 2024 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-38224653
16.
[Clinicopathological features and multivariate analysis of prognostic factors for patients with gastroenteropancreatic neuroendocrine tumors].
Zhonghua Yi Xue Za Zhi
; 93(18): 1411-4, 2013 May 14.
Artículo
en Zh
| MEDLINE | ID: mdl-24025507
17.
Cancer department nurses' attitudes and practices in response to the sexual issues of pelvic radiation patients: a survey in Sichuan, China.
Contemp Nurse
; 43(2): 146-51, 2013 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-23485216
18.
Interim survival analysis of the randomized phase III GEMSTONE-302 trial: sugemalimab or placebo plus chemotherapy as first-line treatment for metastatic NSCLC.
Nat Cancer
; 4(6): 860-871, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37322367
19.
HLA-I Evolutionary Divergence Confers Response to PD-1 Blockade plus Chemotherapy in Untreated Advanced Non-Small Cell Lung Cancer.
Clin Cancer Res
; 29(23): 4830-4843, 2023 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37449971
20.
Central nervous system efficacy of rezivertinib (BPI-7711) in advanced NSCLC patients with EGFR T790M mutation: A pooled analysis of two clinical studies.
Lung Cancer
; 180: 107194, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37163774